Recombinant Human CD158G/KIR2DS5 protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg3719
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human CD158G protein His22-His245 (Accession# Q14953) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 3810 |
Accession | Q14953 |
PredictedSize | 51.0 kDa |
SDS-PAGE | 60-85 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
KIR2DS5, a member of the KIR (killer cell immunoglobulin-like receptor) family, is a cell surface receptor expressed by subpopulations of natural killer (NK) cells and T lymphocytes. KIR2DS5 is an activating receptor that binds to a multimer of DAP12 signaling molecules and transmits activation signals through its short cytoplasmic tail. KIR2DS5 is expressed on NK cells and triggers NK cell functions, including cytotoxicity and cytokine release, upon recognition of certain polymorphisms in HLA-C molecules.
References:
1. Mariella Della Chiesa, et al. (2008). Eur J Immunol. 38(8):2284-9. 2. Noriko K Steiner, et al. (2008). Immunogenetics. 60(11):655-67. 3. Jeroen H Blokhuis, et al. (2017). Immun Inflamm Dis. 5(4):461-468.